NovoCure (NVCR) Gross Margin (2014 - 2026)
NovoCure (NVCR) posted Gross Margin of 77.61% for Q2 2026, little changed sequentially from 77.63% in Q1 2026, and up 372.0% YoY from 16.44% in Q2 2025.
NovoCure (NVCR) Gross Margin (2014 - 2026) Analysis & Trends
NovoCure has reported Gross Margin for 13 years, with the latest figure at 77.61% in Q2 2026.
- Quarterly Gross Margin rose 372.0% year-over-year to 77.61% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 76.13% (down 26.0% YoY) and the FY2025 annual result came in at 74.54%, down 280.0% from the prior year.
- Gross Margin steadied at 77.61% in Q2 2026 per NVCR's latest filing, from 77.63% in the prior quarter.
- Over five years, Gross Margin peaked at 79.84% in Q1 2022 and troughed at 73.01% in Q2 2023.
- A 5-year average of 76.45% and a median of 76.39% in 2024 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2023 and 2024: Gross Margin slumped 675 bps in 2023, then surged 394 bps in 2024.
- Over 5 years, Gross Margin stood at 77.51% in 2022, then slipped by 2 bps to 75.67% in 2023, then gained by 5 bps to 79.25% in 2024, then declined by 4 bps to 75.82% in 2025, then grew by 2 bps to 77.61% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 77.61%, 77.63%, and 75.82% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 45.84% |
| 10 | NovoCure | 2.04 Bn | 1.60 Bn | 142.48 Mn | 77.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.61% |
| Mar 31, 2026 | 77.63% |
| Dec 31, 2025 | 75.82% |
| Sep 30, 2025 | 73.25% |
| Jun 30, 2025 | 73.88% |
| Mar 31, 2025 | 75.15% |
| Dec 31, 2024 | 79.25% |
| Sep 30, 2024 | 77.19% |
| Jun 30, 2024 | 76.95% |
| Mar 31, 2024 | 75.68% |
| Dec 31, 2023 | 75.67% |
| Sep 30, 2023 | 74.79% |
| Jun 30, 2023 | 73.01% |
| Mar 31, 2023 | 75.76% |
| Dec 31, 2022 | 77.51% |
| Sep 30, 2022 | 77.29% |
| Jun 30, 2022 | 79.77% |
| Mar 31, 2022 | 79.84% |
| Dec 31, 2021 | 77.71% |
| Sep 30, 2021 | 77.39% |